Skip to main content

Peer Review reports

From: Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study

Original Submission
23 Jun 2022 Submitted Original manuscript
25 Jun 2022 Reviewed Reviewer Report
1 Jul 2022 Reviewed Reviewer Report - Sabina Cevoli
10 Jul 2022 Reviewed Reviewer Report
5 Aug 2022 Author responded Author comments - Roger Cady
Resubmission - Version 2
5 Aug 2022 Submitted Manuscript version 2
Publishing
9 Aug 2022 Editorially accepted
6 Sep 2022 Article published 10.1186/s10194-022-01482-0

You can find further information about peer review here.

Back to article page